Fresno's adult obesity rate, the January 2026 Medi-Cal change, published local clinic pricing, and the Central Valley specialist gap, with every figure sourced.
37.5% of adults inside Fresno city limits have obesity, according to the CDC's PLACES place-level estimates (2025 release, 2023 survey data) 1. California's statewide adult rate is 29.1% in the CDC's 2024 BRFSS estimates 2. Fresno's city rate runs more than eight points above the state's, and because the two figures come from different survey years we treat that gap as a direction, not a decimal.
The prevalence number is background. What actually changed for Fresno households this year is who pays, and that change arrived on January 1.
Medi-Cal eliminated coverage of GLP-1 medications prescribed for weight loss effective January 1, 2026. Wegovy, Zepbound, and Saxenda were removed from the Medi-Cal Rx Contract Drugs List for weight-management use, per the Department of Health Care Services' own provider bulletin 8. Coverage continues for other indications: a member with type 2 diabetes can still be dispensed a GLP-1 through the benefit, while a member whose only indication is obesity cannot 8.
Fresno County is one of California's most Medicaid-dependent large counties, which is why a formulary change lands harder here than it does in the state's wealthier metros. Fresno's uninsured rate is 6.1% 5 and its median household income is $74,491 6, so for a large share of city residents the Medi-Cal pharmacy benefit was the entire funding plan for this class of drug. If your refill was denied this year, that is a formulary decision written in Sacramento, not a judgement about your chart.
Two Fresno providers publish or describe cash-pay pricing, and their own statements are listed with source links and check dates under Local options below. Optimal Medical Group writes that clinic-based cash-pay semaglutide in Fresno commonly starts near $275 per month, that nearby GLP-1 programs begin around $350 per month at escalated doses, and that its own 12-week program runs about $3,000 all-inclusive 11. Sylvan Med Spa & Weight Loss advertises competitive pricing on semaglutide and tirzepatide but had published no dollar figures as of our August 2026 check, so a quote there requires a phone call 12.
Astra's pricing is the same in every state we serve: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans, or $145 and $250 per month when billed monthly. There is no local price list, no regional surcharge, and no state-specific discount.
That price is not a Fresno offer and it is not an introductory rate. It is the same number a patient in San Francisco or Sacramento sees, and it does not climb when your dose is escalated, which is the point at which locally advertised programs tend to reprice.
UCSF's comprehensive Weight Management Program, the nearest academic obesity-medicine program of that kind, is in San Francisco, about a three-hour drive each way from Fresno 9. UCSF Fresno's own reporting on the new weight-loss drugs points to a single obesity-boarded endocrinologist practicing locally 10. Behind that, HRSA's shortage-area records show Fresno County carrying 25 or more active primary-care shortage designations, including population HPSAs inside the city itself 7.
Distance is the specific problem telehealth solves here. With Astra, an intake is reviewed by a licensed physician usually within 24 hours, medication ships overnight in discreet packaging, there are no clinic visits and no drive over the Pacheco Pass, you can message your care team at any point in treatment, and you are only charged if a physician prescribes.
Astra's provider group and partner pharmacies are licensed to serve patients throughout California, the Central Valley included, so Fresno, Clovis, and the surrounding county are inside our service area on the same terms as the coast. State-level prescribing rules, compounding rules, and the full statute citations live on the California GLP-1 hub.
Astra treats patients in California through state-licensed physicians.
On the published figures, yes. Optimal Medical Group states that clinic-based cash-pay semaglutide in Fresno commonly starts near $275 per month, with nearby programs beginning around $350 per month at escalated doses. Astra's compounded semaglutide is $68 per month on the 12-month plan. That is a national price, not a Fresno deal, and it is the same figure everywhere we operate and at every dose.
For weight loss, yes. Effective January 1, 2026, Medi-Cal removed Wegovy, Zepbound, and Saxenda from the Contract Drugs List for weight management. Coverage remains for certain other indications, including type 2 diabetes, per the Department of Health Care Services bulletin.
No. The entire process is remote: you complete an online intake, a California-licensed physician reviews it, and if it is appropriate the prescription is filled by a partner pharmacy and shipped to your Fresno address. There are no in-person visits and no drive to the Bay Area.
Compounded semaglutide is dispensed by state-licensed US compounding pharmacies under a patient-specific prescription, and it is not an FDA-approved product. California pharmacy law governs what a 503A pharmacy may compound and for whom. The full state rules are on our California GLP-1 hub at /glp-1/california/.
Yes, within limits set by state law: a California-licensed physician may establish the required relationship and prescribe by telehealth. The statutes and their conditions are summarized in the telehealth section of /glp-1/california/.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.